Teva
Mega deal: Teva acquires Emalex for approximately $900 million
The Israeli pharmaceutical giant is accelerating its growth strategy and adding to its portfolio a groundbreaking treatment for Tourette syndrome in children.
IATI CEOs Forum meets in Kiryat Gat to discuss multinational industry resilience
Teva honored for gender equality as women reach 43% of senior management in Israel
Teva collaborates on skin disease treatment, releases targets
Who were the Israeli winners and losers of Wall Street in 2024?
Twelve Israeli companies rose more than 100% on Wall Street in 2024.
Immunai and Teva partner to innovate new cancer, immunology therapies
The collaboration between the two companies reflects ongoing efforts to enhance drug development, the CEO of Immunai said.
EU set to fine Israeli company Teva for disparaging rival multiple sclerosis medicine, sources say
The long-running case against Teva started with EU dawn raids in 2019 that led to the opening of an investigation in 2021.
Teva joins world’s top 20 pharmaceutical companies
After years of financial and legal problems, Israel’s Teva Pharmaceutical Industries Ltd. named No.19 among the world’s top 20 best-earning pharmaceutical companies.
Women leaders reflect on the tragedy of October 7 and the path forward at WLS Conference
Participants in the panel included Prof. Eilat Shinar (MDA), Talia Tzour Avner (JNF-USA), Amalia Adler-Waxman (Teva), Shari Mendes (Israel Lemonade Fund) and lawyer Ayelet Razin Bet Or.
In the healthcare industry, diversity is crucial to serve patients better, says Teva VP
Amalia Adler-Waxman, Senior Vice President, Global Head of Sustainability and Head of Corporate Affairs of International Markets at Teva, spoke at the Jerusalem Post's Women Leaders Summit.
Support the Soul: 'Teva' campaign to strengthen mental resilience
The Teva company enlisted in the national mission and established "Mental Caregivers", a program to strengthen mental resilience.
'Lending a hand': Teva employees worldwide donate refurbished computers to Israelis affected by war
They collected and shipped hundreds of laptops that had been previously used, now repurposed to aid those affected by the conflict.
Digital innovation can help Israel deal with October 7 trauma. Here's how
Speaking at the Israel Summit, Dr. Eran Harary, a psychiatrist and a Senior Vice President at Teva's Global R&D, explained how Israelis can overcome the shock and find themselves more resilient.
Teva to pay Nevada $193 million over role in opioid epidemic
Nevada, along with other states and thousands of local governments, accused Teva and other drugmakers of downplaying the addiction risks of opioid pain drugs.
